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1. Introduction  
The EQ-5D is the most widely used generic preference-based measure of health. A comprehensive 
review showed the instrument had been applied in 63% of 1,682 studies [1]. Another review found 
that 77% of all cost-utility analyses published in 2010 were based on the EQ-5D [2]. Given the 
increasing influence of such analyses in resource allocation decisions, it is timely to inquire into the 
value sets (sometimes referred to as ‘tariffs’) that form the basis for calculating QALYs (quality-
adjusted life years). When a value set is not available for a country where a cost-utility analysis is 
undertaken, a value set from another country would normally be chosen. However, the more the 
value sets in other countries differ, the more sensitive are the estimated QALY-gains, and the 
subsequent cost-effectiveness ratio, to the choice of value set.  
The EQ-5D descriptive system consists of five dimensions: mobility (MO); self-care (SC); usual 
activities (UA); pain/discomfort (PD); anxiety/depression (AD). The original EQ-5D-3L is increasingly 
being supplanted by the EQ-5D-5L with its five severity levels. As of January 2017, value sets for the 
5-level version have been developed for seven countries: Canada, England, the Netherlands, Spain, 
Uruguay, Japan and Korea [3-9]. Given the differences in culture, language, modelling and data 
collection, some systematic variation across the value sets should be expected, despite a common 
protocol.  
The first aim of this paper is to highlight some methodological (dis)similarities before we compare 
the index values in each country. The second aim is to identify some characteristics in preference 
patterns. We distinguish between: i) the relative importance of the five dimensions; ii) the relative 
utility decrement, or distances between each of the five levels, and; iii) the ‘scale-length’ differences 
that reflect the quality vs quantity trade-offs. The third aim is to develop a simplified model that is 
based on similarities in preference patterns that are revealed by a comparison of the value sets of 
the four Western countries: Canada, England, the Netherlands and Spain. Lastly, we compare our 
model with these four value sets, using a large international survey that includes six countries and 
seven diagnostic groups (N = 7,933). 
2. Descriptive comparisons 
All countries used a digital aid called the EuroQol valuation technology (EQ-VT), which is the EuroQol 
standard protocol for EQ-5D-5L valuation studies and a word for word transcribed interview protocol 
[10]. In each country, around 1,000 respondents from representative population samples expressed 
their preferences through the composite time-trade-off (cTTO) method and discrete choice 
experiments (DCE). The EuroQol introduced this composite approach (cTTO), which combines the use 
of conventional TTO for states better than dead, and the lead-time TTO for states worse than dead to 
derive values less than zero [11]. The econometric modelling differed. See Table A1 in the Appendix 
for details on the methodological differences across value sets in the seven countries. 
Comparing the published models is difficult when scoring algorithms are non-additive. Some models 
include a fixed decrement associated with any move from perfect health (all dimensions at level 1; 
11111) referred to as N1 in the modelling to generate the UK 3L value set [12]. Additionally, for some 
countries there are further subtractions depending on how many dimensions are at levels 4 and 5, or 
the use of further rescaling. Hence, to facilitate comparison of value sets, we compute and report the 
index values assigned to all the 20 health states that involve partial decrements along one dimension 
only, i.e. four dimensions are symptom free (level 1), while the remaining dimension has level 2, 3, 4, 
or 5. Where alternative value sets based on different models are available, we use the model 
recommended by the authors.  
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Table I reports index values for each of these 20 partial health state combinations, including: i) the 
range between the highest and the lowest value for the same health state across the seven countries 
and across the four Western countries, referred to as the CENS countries (Canada, England, the 
Netherlands, Spain); ii) median index values for the CENS countries, and; iii) the index values from 
our suggested ‘amalgam model’ WePP (Western Preference Pattern), to be explained below.  
 
Table I: Index values for each country 
 
Generally, Uruguay has the highest values, and Korea the lowest. Japan tends to have low values for 
the non-severe levels 2 and 3, and lies close to the Korean values for these levels.  The differences 
across the three European and the Canadian value sets are much smaller (compare the total range 
with the CENS-range in Table I). The Canadian index values generally lie within the European ranges, 
except for the SC dimension where Canadian values lie below the European values. The CENS-ranges 
are generally small, except for levels 4 and 5 of the PD and AD dimensions, where the Dutch values 
are much lower than those for Canada, England and Spain. 
Figure 1 provides an illustration of Table I. For Canada, England, the Netherlands and Spain, three 
striking similarities in preference patterns emerge on: i) the relative importance of the five 
dimensions; ii) the relative utility decrements along the five levels, and; iii) the ‘scale-length’ that 
reflects the quality vs quantity trade-off.  
 
Figure 1a-b: Pattern of dimensions and levels 
 
3. Three characteristics of preferences 
3.1. The relative importance of the dimensions 
An examination of the relative importance of each dimension shows that similar patterns exist for 
the CENS countries, where the last two dimensions (PD and AD) generally have the highest relative 
importance, i.e. lowest index values in Table I.  Japan and Korea are different, in that the first 
dimension (MO) has the highest relative importance. 
In addition to measuring the dimension importance by cardinal weights, Appendix Table A2 provides 
the ordinal ranking of the decrements at each level, for each country.  These importance rankings 
differ only slightly depending on which level is considered. The same general pattern is confirmed in 
the three European countries and to some extent Canada: PD and AD are ranked highest, 
representing highest relative importance, and have similar ranking scores; MO and SC are ranked 
next, also with similar ranking scores, and; UA is generally ranked lowest. Canada differs slightly, in 
that SC has a higher ranking than MO and UA.  
The relative importance weights (reported in Appendix Figure A1) are obtained by identifying which 
of the five dimensions involves the largest utility decrement at a given level, which is then assigned a 
relative importance of 1.00. The corresponding decrements for the other dimensions are then 
divided by this largest decrement at that level, and assigned a relative importance weight (< 1), as 
illustrated by the length of the coloured lines. Interestingly, the magnitude of the relative differences 
in the weighting of dimensions is much smaller for Japan and Korea, than in the CENS countries. 
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The CENS value sets are broadly similar to the English TTO data [4], which suggest that: i) the MO, SC 
and UA dimensions have quite similar weights; ii) the PD and AD dimensions also have similar 
weights, and; iii) the sum of the first three’s weights is about the same as the sum of the last two’s 
weights. The DCE data in England indicated similar patterns. Based on these observations, Table II 
compares the aggregate of the three ‘functioning dimensions’ (MO, SC, UA) with the two ‘symptom 
dimensions’ (PD, AD) at each level. Again, a similar pattern is confirmed for the CENS countries: the 
aggregate importance of the first three dimensions is similar to the aggregate importance of the last 
two dimensions. As for the other three countries (Uruguay, Japan, Korea) the ‘functioning 
dimensions’ have consistently much higher relative importance. 
 
Table II: The relative importance of functioning vs symptoms 
 
3.2. The relative utility decrements between the levels  
There is no theoretical reason why a move from one level to the next one down involves the same 
marginal disutility. This is simply because the EQ-5D is a descriptive system, whereby the levels under 
each dimension are described as opposed to having a numerical or visual scale with identical intervals 
or space in between. Hence, the utility decrement from one level to the next would reflect 
respondents’ interpretation of the severity differences associated with the words used at each 
particular level. For example, to the ears of most (English speaking) people the distance from 
‘moderate’ to ‘severe’ is larger than the distance from ‘severe’ to ‘extreme’. However, given cultural 
differences and linguistic nuances in translations of the descriptive system, the same relative 
distances between the five levels should not be expected across countries. Still, Figure 1 illustrates 
some striking similarities across the three European countries, each with their own language.  
Table III compares the values assigned to the different levels of the scale, when each dimension is 
described at the same level. The drop from 11111 to 22222 includes the constant term, N1, which is 
part of the value sets in all countries except Canada and England. Generally, the decrements from 
level 1 to level 2 are larger than from level 2 to level 3. The largest falls occur from level 3 to 4.  
The three European countries appear to be quite similar. Canada follows the same pattern, except 
for the drop from 11111 to 22222 being identical to that from 22222 to 33333. The latter drop for 
the European countries is much smaller. Interestingly, in all four CENS countries, half the scale length 
is located between levels 3 and 4. The differences between levels 4 and 5 are fairly small. This similar 
pattern of scale length distribution, observed in the CENS countries, is not observed in the other 
three countries’ value sets. 
 
Table III: The proportion of the scale length occurring between levels 
 
3.3. Scale length differences 
Beyond the (dis)similar pattern of relative utility decrements, the scale lengths differ; with 55555 
having its lowest value -0.446 in the Netherlands and its highest -0.025 in Japan. For the CENS 
countries, the median value at 55555 is -0.25. To facilitate comparison across different scale lengths , 
Table III includes the proportions of the total scale length across the four intervals. Note that the 
major part of the differences in the length of scales occurs in the bottom half of the scale (between 
levels 33333 and 55555). 
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3.4. An underlying preference pattern 
Based on the above, some characteristics of the seven value sets are extracted and compared in 
Table IV. Some striking similarities can be observed across the value sets in Canada, England, the 
Netherlands and Spain. 
Table IV: Key characteristics of the value sets 
 
To reiterate the similarities in the CENS countries’ value sets: the aggregate weight of the two 
‘symptom dimensions’ (PD and AD) is about the same as  the three ‘functioning dimensions’ (MO, SC, 
UA). PD and AD are quite similar in importance. MO and SC are also quite similar, and UA has 
generally the lowest importance. Decrements from level 1 to level 2 are generally larger than from 
level 2 to level 3. The drop from level 3 to 4 is large, particularly so for dimensions PD and AD. The 
differences in index values are fairly small in the upper part of the descriptive system (levels 2 and 3) 
but larger when health problems become more severe (levels 4 and 5). 
4: Towards a common Western currency 
4.1. Western Preference Pattern 
The similarities observed in the CENS values sets reveal a preference pattern that can provide a basis 
for developing a common currency. More specifically, the WePP (Western Preference Pattern) model 
is derived based on the following observations: 
The ordinal ranking of weights across the five dimensions 
From Table I, Figure 1a and Figure A2: 
i) PD = AD  
ii) MO = SC at levels 2 – 4; MO > SC at level 5 
iii) MO ≥ SC > UA 
 
From Table II:  
(1) PD + AD = MO + SC + UA  
 
Thus, the ordinal ranking can be summarized: 
(2) PD = AD > MO ≥ SC > UA 
   
The relative utility decrements along the five levels 
Figure 1a illustrates a distinct pattern of relative utility decrements for each of the five dimensions in 
each of the CENS-countries: The smallest drops occur between levels 2 and 3 and the largest 
between levels 3 and 4. Furthermore, drops from levels 1 to 2 appear to be larger than those 
between levels 4 and 5.  
 
This pattern of relative utility drops is supported by Table III. As a general approximation, we aim for 
the relative decrements in WePP to correspond as closely as possible with those observed for the 
CENS-median, i.e. third last column of Table III.   
 
The total scale length: 
Two of the four CENS countries’ value sets include a small fixed constant (N1) subtracted for all 
health state combinations other than 11111. A closer look at the CENS-median values in Tables I and 
III suggests an implicit N1 term of about 0.03. This would have implied a 55555 value of – 0.23, which 
comes close to the CENS-median for 55555 (– 0.25) reported in Table III. Hence, we seek a scale 
length for WePP similar to that for the CENS median. 
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The WePP model was derived based on an observed underlying preference pattern, as expressed by: 
i) the ordinal importance weights in equations (1) and (2); ii) the relative utility decrements for the 
CENS median in Table III, and; iii) the scale length of the CENS median (i.e. 55555 in Table III). In 
addition, a crucial premise was to minimize discrepancies between the modelled values and the 
CENS-median values. Hence, with identical level for all dimensions, the CENS-median column in Table 
III suggests equations (3a-d) should be satisfied, where the sub-scripts refer to levels, and the 
numbers refer to 1 minus the CENS-median values reported in Table III:  
 
(3a) N1 + MO2 + SC2 + UA2 + PD2 + AD2 ≈ 0.29 (1 – 0.71) 
(3b) N1 + MO3 + SC3 + UA3 + PD3 + AD3 ≈ 0.44 (1 – 0.56) 
(3c) N1 + MO4 + SC4 + UA4 + PD4 + AD4 ≈ 1.04 (1 – (-0.04)) 
(3d) N1 + MO5 + SC5 + UA5 + PD5 + AD5 ≈ 1.25 (1 – (-0.25)) 
 
After several alternative value sets were explored, the WePP value set presented in Box 1, using two 
decimals only, came closest to equations (1) – (3a-d).  
 
 
Box 1: The WePP (Western Preference Pattern) model 
Dimensions  
 
MO 
 
SC 
 
UA 
 
PD AD 
 
Level 2 0.04 0.04 0.03 0.06 0.06 
Level 3  0.07 0.07 0.06 0.10 0.10 
Level 4 0.17 0.17 0.16 0.25 0.25 
Level 5 0.22 0.20 0.19 0.30 0.30 
Full health (11111): 1.00;          Constant (N1):  0.03 
 
 
Equation (1) is satisfied at levels 3 and 4. At level 2, PD + AD = 0.12 > MO + SC + UA = 0.11, and at 
level 5, there is a reverse absolute difference (0.01). Thus, when considering the aggregate of the 
four comparisons, the equation holds.  
 
As for Equation (2), PD = AD at all levels. MO = SC at levels 2 – 4, while MO > SC at level 5. UA has 
slightly lower values than SC at each level.  
 
Generally, when comparing WePP with the CENS median values, we observe a very close 
correspondence: Among the 20 index values reported in Table I, 7 are identical. For 6 combinations 
WePP is 0.01 higher than CENS, while the reverse discrepancy is observed for 5 combinations. In the 
remaining two combinations, the discrepancy is 0.02, one in each direction. Among the discrepancies 
between symptoms vs functioning items at different levels, Table II reports a similarly close 
correspondence between WePP and CENS median values. As to the proportions of the scale lengths 
between levels, Table III shows a two percentage point discrepancy in each direction in two of the 
four level intervals. Finally, with respect to the total scale length, there is a 0.01 difference between 
WePP and the CENS median for the 55555 combination.  
 
Note that the CENS values are medians, whereas, the WePP values are the values implied if the value 
set is to conform to a series of rules suggested by characteristics shared by the four value sets. The 
WePP model is based on some striking similarities in the preference patterns revealed from each of 
the four value sets, emphasizing the ordinal ranking and the relative differences across dimensions 
and levels. From these extracted patterns, an amalgam model is developed.  
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4.2 How does WePP perform? 
The proposed WePP model and each of the value sets in the CENS countries were compared using 
data from the Multi Instrument Comparison (MIC) study, which includes seven major ‘disease groups’ 
(arthritis, asthma, cancer, depression, diabetes, hearing loss, heart diseases) and a ‘healthy’ group 
(who did not have any known diagnosis) in six OECD-countries (Australia, Canada, Germany, Norway, 
UK, US) [13].  
In the total sample of 7,933 respondents, as many as 1,530 described their health at 11111. Of the 
remaining 6,403 in non-perfect health: 50% reported only level 2 in one or more dimensions; 30% 
had levels 3, 2 or 1; 15% had levels 4, 3, 2 or 1, and the remaining 5% had level 5 in one or more 
dimensions. In other words, in this large study including seven chronically ill patient groups, only 20% 
had reported a health state combination that includes levels 4 or 5 in at least one dimension.  
Based on these data, we can identify differences in mean health state values in the WePP model vs 
the four value sets from the CENS countries across the whole severity range. We take the summary 
score (from 11111 = 5 to 55555 = 25) and transform it to an unweighted [0 – 1]-scale, in which 11111 
is assigned 1.00, and 55555 is assigned 0.00. Figure 2a provides detailed distribution of the mean 
values for the 21 unique levels of the transformed summary score, for the total sample. Interestingly, 
the WePP values lie within the confidence intervals for the value sets in Canada, England, Spain 
across the whole severity distribution.  
 
Figure 2 a-b: Mean index values by transformed summary score, CENS countries and WePP 
 
Generally, the index values in WePP appear to lie close to the English and Canadian values. An 
analysis of the agreement between WePP and each of the four CENS value sets revealed strong 
degrees of concordance: [ICC=0.990; 95% CI: (0.977, 0.995)] for the English value set, followed by 
Canada [ICC=0.989; 95% CI: (0.987, 0.990)], Spain [ICC= 0.985; 95% CI: (0.968, 0.991)] and the 
Netherlands [ICC=0.945; (95% CI: 0.787, 0.976)]. Similarly, the mean difference is minimal at the 
group level when compared with the value sets in Canada (-0.006), England (0.014), and Spain (-
0.016). The mean difference when compared with the Dutch value set is higher (-0.045), which is 
expected since the Dutch index values were generally lower than the other three CENS countries. The 
WePP model has a narrow variation in the 95% limits of agreement (LOA) when compared to the 
English value set [95% LOA: (-0.031, 0.058)], indicating small variation between the two measures at 
the individual level as well. While this 95% LOA is relatively moderate in Canada [95% LOA: (-0.058, 
0.046)] and Spain [95% LOA: (-0.072, 0.041)], it is considerably higher for the Dutch value set 
(particularly among individuals with poorer health states); i.e. the 95% LOA: (-0.153, 0.064).  
Furthermore, to see if the WePP model performs differently for physical vs mental/psychological 
symptoms, it was assessed in two disease groups, arthritis (N=929) and depression (N=917). In the 
arthritis group, the results are consistent with the analyses based on the total sample (see Appendix 
Figure A2). The findings reveal a very strong agreement between the WePP model and the Canadian 
tariff [ICC=0.995; 95% CI: (0994, 0.995)] followed by the English tariff [ICC=0.988; 95% CI: (0.977, 
0.992)].  A relatively high agreement has been observed with Spain [ICC=0.977; 95% CI: (0.924, 
0.989)] and the Netherlands [ICC=0.933; 95% CI: (0.927, 0.973)]. Similar performance was observed 
in the depression group: the level of agreement as measured by ICC between the WePP and the 
Canadian, the English, the Spanish, and the Dutch tariffs were 0.995, 0.991, 0.983, and 0.891, 
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respectively. The variation between the proposed WePP model and the CENS value sets (as measured 
by the 95% LOA) in the two disease groups were also small. In the arthritis group, the 95% LOA with 
Canada was (-0.038, 0.039), with England (-0.042, 0.070), with Spain (-0.090, 0.042), and with the 
Netherlands (-0.173, 0.063). The respective values for the depression group were (-0.025, 0.045), 
(0.038, 0.062), (-0.082, 0.047), and (-0.225, 0.039). Our results indicate the highest discrepancy from 
the Netherlands tariff (at the individual level) with the width of the 95% limits of agreement equal to 
0.236 for the arthritis group and 0.264 for the depression group. Hence, the WePP model appears to 
perform equally well for physical and mental symptoms.  
To test if the WePP model performs better than the CENS median model, we compared the degree of 
agreement that the WePP model represents, with those between the CENS median value set for each 
of the four countries. The WePP model performed better in three of the four countries. Only for 
Canada did the CENS median model give a slightly stronger degree of concordance (0.995 as 
compared to 0.990 for WePP).  
Despite its breadth in terms of diagnoses, the MIC data only includes 566 (18%) of the 3,125 unique 
health state combinations in the 5L instrument. In order to locate WePP in relation to each of the 
four CENS countries’ value sets, Figure 2b considers the same dimensions as Figure 2a, by taking the 
mean preference based value (and confidence interval) at each level of the transformed summary 
score. The mean values of the WePP lie within the confidence intervals of the value sets from Canada 
(except at the bottom end), England and Spain.  
A quite different test of WePP’s performance is to compare its index values with the observed TTO 
values of the health state combinations on which the EQ-5D-5L modelling is based. The Dutch study 
reports these cTTO values for each of the 86 combinations included. However, most of them appear 
to be extremely rare or non-existent in practice. The 7,933 subjects in the MIC study report only 19 of 
the 86 combinations. However, 10 of which are rare with only 1 to 4 subjects in each. The remaining 
9 more prevalent health state combinations (i.e. with 5 or more subjects) represent mild conditions 
in that they include level 2 in one or two dimensions. When comparing the cTTO based values with 
those of the Dutch model, and the WePP value set, the WePP comes closer to the observed values 
than does the Dutch model (Appendix Table A3) for 8 of these 9 health states.  However, it remains 
to test the degree of misspecifications in the moderate or severe states (levels 3, 4 and 5), and for 
the other countries’ value sets.  
5: Discussion and conclusion  
The seven recently published value sets for the EQ-5D-5L instrument are expected to differ because 
of differences in cultures, norms and wealth impact upon people’s health state preferences. In 
addition to variations explained by preference diversity across countries, differences in the published 
value sets will also depend on: i) which elicitation method was used (TTO or DCE); ii) which modelling 
was chosen, and; iii) the quality of data collection.  
Our inquiry into (dis)similarities across the seven value sets revealed some characteristic preference 
patterns in the four Western countries, Canada, England, the Netherlands and Spain. As to the 
relative importance of the dimensions, the two symptom dimensions (PD and AD) have similar 
weights. Their total weight is roughly similar to the total weight of the three functioning dimensions 
(MO, SC, UA), which also appear to have quite similar weights. As to the relative decrement from one 
level to the next one down, these are non-linear with three distinct ‘kinks’; small decrements from 
level 2 to 3; large decrements from level 3 to 4, and; small decrements from level 4 to 5. As for the 
total scale lengths, they all stretch below zero to include states worse than dead. However, the value 
for the 55555 state differs across the countries.   
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Most researchers with some experience in preference elicitation would admit that respondents do 
not hold precise, stable preferences over hypothetical health states (see e.g. [14]). Rather, a 
respondent’s valuation of a described health state would depend on the elicitation method used (the 
question asked), and a wide range of framing effects. However, while people may have difficulties in 
expressing exact cardinal values for alternative health states, they may have a clear idea of their 
ordinal ranking. Furthermore, they may have an idea of the relative values, e.g. that a symptom 
dimension is one and a half times as important as a functioning dimension. The rationale behind our 
search for a common currency was to identify any such preference patterns observed when 
comparing value sets from different countries.  
An amalgam model, WePP, was presented to accommodate the key characteristics of preference 
patterns observed in the CENS countries (Canada, England, the Netherlands and Spain). The 
agreement of this model with the value set from each of these countries proved to be very strong, 
and better than the agreement produced by the CENS median model. Our comparisons lend support 
to the finding that ‘East does not meet West’ in health state utilities, and that there is less variation 
in the Western countries [15]. 
We have demonstrated a successful implementation of an approach based on the distilled common 
characteristics of several value sets. Still, the WePP value set will be vulnerable to problems 
characterising the source of the data, namely hypothetical bias. Modelled values will always differ 
from observed values. The modelled values may be a better approximation to the population values 
than those observed. However, in order to obtain a model that reflects the complete severity range, 
some health state combinations are included that are extremely rare in practice. The problem is that 
the more unreal – or constructed – a described health state combination appears to respondents, the 
more hypothetical bias is likely to be introduced in the preference elicitation exercise. This problem 
may arise for those health state combinations which few respondents have experienced, i.e. those 
which include levels 4 or 5 (‘severe’ and ‘extreme’/’unable’), and particularly when there is no 
corresponding severities for the symptom items (PD or AD).  For example, in the MIC data, only 94 
out of the 6,403 respondents with a health state different from 11111 reported a decrement in any 
of the functioning items without also reporting a decrement in either of the two symptom items. Ten 
health state combinations covered 50% of respondents, while 50 combinations covered more than 
75%. When the vast majority of the 3,125 possible combinations in the 5L system involve potential 
hypothetical bias, and there are strong arguments put forward for eliciting experienced preferences, 
there is a case for taking prevalence into account when designing data collection. 
The EQ-5D has a dominant position in the estimation of QALY-gains. In order to maintain its key role 
in applied analyses of high policy relevance, it is important to apply valid and reliable value sets. 
Some unresolved issues remain: to what extent do the observed differences in value sets reflect 
genuine preference heterogeneities across these countries, and to what extent do they result from 
differences in modelling, or the quality of the data collection? This paper has identified some 
consistent preference patterns. The use of a ‘common currency’ like the WePP might be a useful 
option in other Western countries that have yet to develop their own value sets.  
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